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Sac1 phosphoinositide (PI) phosphatases are essen-
tial regulators of PI-signaling networks. Yeast Sac1,
an integral endoplasmic reticulum (ER) membrane
protein, controls PI4P levels at the ER, Golgi, and
plasma membrane (PM). Whether Sac1 can act in
trans and turn over PI4P at the Golgi and PM from
the ER remains a paradox. We find that Sac1-medi-
ated PI4P metabolism requires the oxysterol-binding
homology (Osh) proteins. The PH domain-containing
family member, Osh3, localizes to PM/ERmembrane
contact sites dependent upon PM PI4P levels. We
reconstitute Osh protein-stimulated Sac1 PI phos-
phatase activity in vitro. We also show that the ER
membrane VAP proteins, Scs2/Scs22, control PM
PI4P levels and Sac1 activity in vitro. We propose
that Osh3 functions at ER/PM contact sites as both
a sensor of PM PI4P and an activator of the ER
Sac1 phosphatase. Our findings further suggest
that the conserved Osh proteins control PI metabo-
lism at additional membrane contact sites.
INTRODUCTION
Phosphatidylinositol 4-phosphate, PI4P, serves as an essential
signaling molecule at the plasma membrane (PM) and Golgi in
the control of membrane trafficking, cytoskeletal organization,
lipid metabolism, and signal transduction pathways (D’Angelo
et al., 2008). Maintaining the proper balance of PI4P levels
through the regulation of phosphoinositide (PI) kinases and
phosphatases is critical. Sac1-like PI phosphatases are impor-
tant regulators of PI4P turnover and are implicated in disease
(Liu and Bankaitis, 2010). Yeast cells lacking Sac1 display
elevated PI4P levels resulting in impaired membrane trafficking,
abnormal vacuolar morphology, altered lipid metabolism, and
growth defects (Foti et al., 2001; Guo et al., 1999; Rivas et al.,
1999). Inactivation of Sac1 PI phosphatase activity provided by
Sac1 and the synaptojanin-like proteins, Sjl2 and Sjl3, resultsin massive PI4P accumulation, secretory defects, and lethality
(Foti et al., 2001). In mammalian cells, depletion of Sac1 leads
to elevated cellular PI4P levels, Golgi fragmentation, and defects
in mitotic spindle organization (Liu et al., 2008). Loss of Sac1 in
the mouse and Drosophila results in embryonic lethality
(Liu et al., 2008; Wei et al., 2003). Thus, Sac1 PI phosphatases
are essential for multiple, conserved cellular functions.
Although Sac1 PI phosphatases are key modulators of PI4P
metabolism, little is known about their regulation. Both yeast
and mammalian Sac1 are integral membrane proteins localized
to the endoplasmic reticulum (ER) and Golgi (Faulhammer
et al., 2007; Foti et al., 2001; Nemoto et al., 2000). Upon starva-
tion in yeast, or in the absence of growth factors in mammalian
cells, Sac1 traffics from the ER to the Golgi where it antagonizes
PI4P synthesis and Golgi function (Blagoveshchenskaya et al.,
2008; Faulhammer et al., 2007). Although roles for Sac1 in the
control of PI4P pools at the ER and Golgi are known, less is
understood about how Sac1 regulates PI4P levels at the PM.
Previous studies indicate that sac1Dmutant yeast cells accumu-
late PI4P at the PMgenerated by the PI 4-kinase Stt4 (Baird et al.,
2008; Foti et al., 2001; Roy and Levine, 2004). Yet, Sac1 is not
known to traffic to the PM, nor is it known if Sac1 regulates PM
PI4P pools from the ER. A recent study describing the molecular
structure of the Sac1 catalytic domain suggests that Sac1 may
act in trans from the ER to turn over PI4P at the PM (Manford
et al., 2010). However, factors that link Sac1 PI phosphatase
activity to PI4P at the PM are unknown.
We find that PI4P metabolism and Sac1 function require the
oxysterol-binding homology (Osh) protein family. In particular,
Osh3 assembles at cortical ER (cER) structures in response to
PM PI4P levels. We reconstitute Osh protein-stimulated Sac1
PI phosphatase activity against PI4P-containing liposomes
in vitro. In addition the ER membrane VAP proteins, Scs2 and
Scs22, control PM PI4P levels in vivo and Sac1 activity in vitro.
We propose that the Osh and VAP proteins regulate Sac1 PI
phosphatase activity at PM/ER membrane contact sites. We
also discuss potential roles for these proteins in the control of
PI metabolism at additional membrane contact sites. Membrane
junctions between the ER and other organelles are sites for lipid
transfer and metabolism, Ca2+ transport and signaling, and the
downregulation of insulin and growth factor receptors (reviewedCell 144, 389–401, February 4, 2011 ª2011 Elsevier Inc. 389
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Figure 1. The Yeast OSBPs Control PI4P
Metabolism
(A) Sac1-GFP localizes to the ER (marked by
DsRed-HDEL). Peripheral ER and nuclear ER (nER)
compartments are labeled. Scale bar, 4 mm. See
also Figure S1B.
(B) Electron microscopy of a region of a yeast
spheroplast showing proximity between cER and
the PM (top, scale bar, 100 nm). Model for PI4P
metabolism at PM/ER membrane contact sites
(bottom).
(C) Diagram of the Osh proteins and OSBP. ORD,
OSBP-related sterol-binding domain; FFAT,
di-phenylalanines within an acidic track; PH,
pleckstrin homology domain; GOLD, Golgi locali-
zation domain; Ank, ankyrin repeats.
(D) Cellular PI4P levels measured by 3H-inositol
labeling and HPLC analysis for wild-type, oshD
[CEN OSH4], oshD [CEN osh4ts], and sac1D cells
at 26C (gray) and 38C (black). Error bars are the
SD of three experiments. See also Figure S1C and
Table S3.
(E) PI4P localization in wild-type, oshD [CEN
OSH4], oshD [CEN osh4ts], and sac1D cells. Wild-
type, oshD [CEN OSH4], and oshD [CEN osh4ts]
cells carrying GFP-2xPHOsh2 were shifted to 38C
for 1 hr; sac1D cells were observed at 26C. Scale
bar, 4 mm.in Lev, 2010). Thus, modulation of PI levels at membrane contact
sites may provide a fundamental mechanism for signaling
between cellular membrane compartments.
RESULTS
The Osh Proteins Regulate PI4P Metabolism
Yeast Sac1 is an integral membrane protein that localizes to
nuclear and peripheral ER compartments (Figure 1A) (Foti
et al., 2001). Yet, PI4P is generated by the PI 4-kinases Stt4
and Pik1 at the PM and the Golgi, respectively (Figure 1E) (Aud-
hya et al., 2000). It is not known whether ER-embedded Sac1390 Cell 144, 389–401, February 4, 2011 ª2011 Elsevier Inc.turns over these distinct PI4P pools.
Sac1 traffics between the ER and Golgi
to regulate PI4P levels at these intracel-
lular compartments (Faulhammer et al.,
2007). However, to our knowledge, Sac1
has not been found at the PM. We
reasoned that ER-localized Sac1 might
control PM PI4P pools at PM/ER
membrane contact sites where the
peripheral ER closely apposes the PM
(within 10 nm) (Figure 1B). Although
Sac1 localizes to the peripheral ER (Fig-
ure 1A), no proteins that regulate Sac1
activity at PM/ER membrane contact
sites are known.
We hypothesized that a PI4P effector
might link PI4P at the PM to Sac1 at the
ER (Figure 1B). For this we focused on
the PI4P-binding proteins Osh1, Osh2,and Osh3, members of the oxysterol-binding protein homology
family (Figure 1C). Osh2 and Osh3 possess PH domains that
bind PI4P and localize to cortical, punctate structures (Figure 1C,
Figure 2A, and Figure S2 available online) (Levine and Munro,
2001; Roy and Levine, 2004). Osh1 also contains a PH domain
but localizes to the Golgi and nuclear-vacuolar membrane junc-
tion sites (Levine and Munro, 2001). Osh1, Osh2, and Osh3 are
similar to mammalian oxysterol-binding protein (OSBP) that
contains a PI4P-binding PH domain (Figure 1C). These proteins
are members of the OSBP-related protein (ORP) family that
contain sterol-binding OSBP-related domains (ORDs) (Fig-
ure 1C). Among the ORP family, Osh4/Kes1 does not possess
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Figure 2. Osh2 and Osh3 Localize to PM/ER
Contact Sites and Control PM PI4P
(A) Osh3-GFP localization in wild-type cells coex-
pressing the DsRed-HDEL ER marker. Arrows
show Osh3-GFP puncta associated with cER. The
asterisk shows an Osh3-GFP patch not associ-
ated with the cER. See also Figure S2A.
(B) Cellular PI4P levels in wild-type and osh2D
osh3D mutant cells measured by 3H-inositol
labeling and HPLC analysis (left). Error bars are the
SD of three experiments. See also Table S3.
GFP-2xPHOsh2 (PI4P) localization in wild-type or
osh2D osh3D mutant cells (right). Mother cells are
indicated (m).
(C) Osh3-GFP localization in wild-type or stt4ts
cells at 38C. Levels were enhanced using Adobe
Photoshop in the DIC overlay image for stt4
mutant cells (lower left). See also Figure S2B.
(D) Growth of oshD [CEN osh4ts] cells coexpress-
ing OSH3 alleles. Serial dilutions of cells carrying
empty vector or Osh3-GFP constructs were incu-
bated at 26C and 38C. Osh3-GFP mutant
constructs are indicated: AAAT, substitution of
phenylalanines in the FFAT motif with alanine,
DPH, deletion of the PH domain. See also Fig-
ure S2C. Scale bars, 4 mm.a PH domain but also binds PI lipids (Figure 1C) (Li et al., 2002).
Osh4/Kes1 is also known to regulate PI4P levels at the Golgi
(Fairn et al., 2007; Li et al., 2002). Given the properties of the
Osh protein family to bind PI4P, regulate PI4P (in the case of
Osh4/Kes1), and to localize to membrane contact sites, we
further examined the role of theOsh proteins in PI4Pmetabolism.
First, we measured PI4P levels in cells lacking Osh protein
function. For this we utilized strains that lack the OSH1-OSH7
genes and carry wild-type OSH4 or a temperature-sensitive
allele, osh4-1, on a plasmid because loss of all Osh proteins is
lethal (oshD:CEN OSH4 or oshD:CEN osh4ts cells) (Beh and
Rine, 2004). In 3H-inositol labeling experiments, PI4P levels
were 6- to 7-fold higher than wild-type cells in oshD:CEN
OSH4 and oshD:CEN osh4ts cells at the permissive temperature
(26C) (Figure 1D), suggesting that Osh proteins (other than
Osh4) control PI4P levels in vivo. At the restrictive temperature
for oshD:CEN osh4ts cells, PI4P levels were elevated 18-fold
above wild-type levels (38C) (Figure 1D) and were greater
than PI4P levels in sac1D mutant cells (13-fold above wild-
type) (Figure 1D). Expression levels of a Sac1-GFP fusion
were slightly reduced in oshD:CEN osh4ts mutant cells atCell 144, 389–40138C (approximately 3-fold) (Figure S1A).
This did not account for the 18-fold
increase in PI4P in oshD:CEN osh4ts cells
because complete loss of Sac1 resulted
in only a 13-fold increase in PI4P (sac1D
cells) (Figure 1D). Moreover, GFP-Sac1
localized to both nuclear and peripheral
ER compartments in wild-type and
oshD:CEN osh4ts cells at 38C (Fig-
ure S1B). The 18-fold increase in PI4P
levels in oshD:CEN osh4ts mutant cellsresembled levels previously reported for triple mutant sac1ts
sjl2D sjl3D cells (Foti et al., 2001), suggesting that the Osh
proteins may regulate multiple Sac1-like PI phosphatase activi-
ties. We also examined PI4P levels in cells lacking both Sac1
and Osh protein function to test for additive effects. PI4P levels
were not further elevated in sac1ts oshD:CEN osh4ts cells
compared to oshD:CEN osh4ts cells at 38C (Figure S1C and
Table S3), suggesting that Sac1 and the Osh proteins act in
a common pathway. Together, these results implicate the Osh
proteins in PI4P metabolism and Sac1 phosphatase function.
The PI4P FLARE (fluorescent lipid-associated reporter)
GFP-2xPHOsh2 is found at Golgi compartments and the PM via
Pik1 andStt4PI 4-kinase activities, respectively, in wild-type cells
(Figure 1E) (Roy and Levine, 2004). In contrast the PI4P FLARE
wasstabilizedat thePM inoshD:CENOSH4andoshD:CENosh4ts
cells, although weak fluorescence at intracellular puncta was de-
tected (Figure 1E). The PI4P FLARE was also increased at the PM
in sac1D cells, consistent with elevated levels of Stt4-generated
PI4P at the PM (Figure 1E) (Baird et al., 2008; Foti et al., 2001;
RoyandLevine, 2004). Althoughprevious studies have implicated
oneOsh familymember, Osh4/Kes, in PI4P regulation at theGolgi, February 4, 2011 ª2011 Elsevier Inc. 391
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Figure 3. The VAP Proteins Scs2 and Scs22
Control PM PI4P Metabolism
(A) Diagrams of mammalian VAP, yeast Scs2/Scs22,
OSBP, and Osh3. VAP proteins possess a major sperm
protein domain (MSP), a coiled-coil, and a transmembrane
domain (TMD).
(B) The GST-Osh31–613 fusion binds Scs2-3xHA from
solubilized yeast lysates. GST alone does not bind Scs2-
3xHA. Total input and bound fractions are shown.
(C) Cellular PI4P levels in wild-type and scs2D scs22D cells
measured by 3H-inositol labeling and HPLC analysis. Error
bars show SD of three independent experiments. See also
Table S3.
(D) Localization of GFP-2xPHOsh2 (PI4P) in wild-type and
scs2Dscs22D cells. Mother cells are indicated (m). Scale
bar, 4 mm. See also Figure S3.(Fairn et al., 2007; Li et al., 2002), our results suggested that addi-
tional Osh proteins control PI4P metabolism at the PM.
Osh3 Localizes to PM/ER Contact Sites in a PI4P-
Dependent Manner
Several lines implicated Osh2 and Osh3 in the control of PI4P
metabolism at the PM. First, both bind PI4P and localize to
cortical structures (Figure 1C, Figure 2A, and Figure S2A) (Levine
and Munro, 2001; Roy and Levine, 2004; Schulz et al., 2009).
Second, expression of OSH2 or OSH3 from a plasmid partially
rescued the increased PI4P levels in oshD:CEN osh4ts mutant
cells at 38C (from 18-fold above wild-type to 5- and 8-fold,
respectively) (Table S3). Third, osh2D osh3D double mutant cells
displayed elevated PI4P levels, as measured by 3H-inositol
labeling experiments (2.7-fold above wild-type) (Figure 2B and
Table S3). Lastly, the PI4P FLARE was stabilized at the PM in
osh2D osh3D double mutant cells (particularly in mother cells),
compared to wild-type cells (Figure 2B).
We examined if Osh3 localized to PM/ER membrane contact
sites in order to regulate PI4P at the PM. Osh3-GFP localized
to cortical patches often associated with cER compartments
marked with DsRed-HDEL (Figure 2A, arrows), as well as the
PM stained with filipin (Figure S2A). To confirm that Osh3
patches associated with cER, we examined Osh3-GFP localiza-
tion in cells lacking the reticulons Rtn1, Rtn2, and Yop1 because
the cER displays expanded sheet-like structures in these mutant392 Cell 144, 389–401, February 4, 2011 ª2011 Elsevier Inc.cells (Voeltz et al., 2006). Osh3-GFP patches
clustered at cER compartments (marked with
DsRed-HDEL) adjacent to the PM (stained with
filipin) in rtn1D rtn2D yop1D triple mutant cells
and was absent from regions lacking cER struc-
tures (Figure S2A). Together, our results sug-
gested that Osh3 localizes to PM/ERmembrane
contact sites and modulates PM PI4P levels,
possibly by regulation of cER-localized Sac1.
Osh3 localization did not always coincide with
cER compartments (Figure 2A, asterisk), sug-
gesting that its assembly at PM/ER membrane
contact sites may be dynamic and progress in
regulated stages. Thus, we tested if Osh3 locali-
zation and function requiredPMPI4P.Osh3-GFPlocalized diffusely in the cytoplasm in cellswith impairedStt4PI 4-
kinase activity (stt4ts cells; Figure 2C), showing thatOsh3 localiza-
tion required PM PI4P synthesis. In contrast, Osh3-GFP was
present at the PM in pik1tsmutant cells impaired in PI4P synthesis
at the Golgi, although Osh3 was observed at intracellular struc-
tures in these cells (Figure S2B). Likewise, Osh3-GFP localized
to cortical patches in cells with reduced PI(4,5)P2 levels (mss4
ts
cells) (Figure S2B). A form of Osh3 lacking its PH domain
(Osh3DPH-GFP) did not rescue the growth defects of oshD:CEN
osh4ts mutant cells at 38C (Figure 2D). In addition, Osh3DPH-
GFP displayed increased cytoplasmic localization, compared to
wild-type Osh3-GFP (Figure S2C). Thus, the assembly of Osh3
at cortical patches required PM PI4P synthesis, consistent with
its ability to bind PI4P and control PM PI4P levels.
Next, we asked if other regions in Osh3 play a role in its func-
tion. Osh3 contains an FFAT motif (di-phenylalanines within an
acidic track) (Figures 1C, 2D, and 3A). FFAT motifs bind the
MSP domains of the yeast ER membrane proteins Scs2 and
Scs22, orthologs of the mammalian ER membrane VAP proteins
(Figure 3A) (Kaiser et al., 2005; Loewen et al., 2003). A form of
Osh3 bearing substitutions in the FFAT motif (Osh3AAAT-GFP)
partially rescued the growth defects of oshD:CEN osh4ts cells
at 38C (Figure 2D) and assembled at cortical patches (Fig-
ure S2C). A previous study reported that a mutant form of
Osh3 with substitutions in the FFAT motif was mislocalized
from the cER (Loewen et al., 2003). However, this study used
a GFP-Osh3 fusion that required Scs2 overexpression to target
to the cER. Consistent with this previous study, we found that
Osh3-GFP targeting to the cER was impaired in scs2D scs22D
double mutant cells (see Figure S3D). As expected, substitution
of the FFAT motif in combination with deletion of the PH domain
(GFP-Osh3DPH, AAAT) (Figure 2D) resulted in inactivation of Osh3
because this mutant protein did not rescue the growth defect of
oshD:CEN osh4ts cells (Figure 2D). Moreover, Osh3DPH,AAAT-
GFP localized diffusely in the cytoplasm, and not at cortical
patches (Figure S2C). Thus, Osh3 undergoes multiple interac-
tions involving at least PI4P and the Scs2/Scs22 VAP proteins
to assemble and function at PM/ER membrane contact sites.
The VAP Proteins Scs2 and Scs22 Regulate PI4P
Metabolism
We then addressed if the ER membrane VAP proteins Scs2/
Scs22 control Osh3 function and PI4P metabolism. Because
FFAT motifs from OSBP and Osh proteins bind VAP proteins
(Figure 3A) (Kaiser et al., 2005; Loewen et al., 2003), we
specifically confirmed interactions for Osh3 and Scs2. A GST-
Osh3 N-terminal fragment containing the FFAT motif (GST-
Osh31–613) (Figure 3A) bound to glutathione-sepharose beads
efficiently isolated an Scs2-3xHA fusion from solubilized cell
extracts (Figure 3B). GST alone was unable to bind Scs2-3xHA
(Figure 3B). We then tested if the VAP proteins Scs2/Scs22
impact PI4P metabolism. PI4P levels were elevated 2.9-fold
above wild-type in scs2D scs22D double mutant cells, as
assessed by 3H-inositol labeling (Figure 3C and Table S3). The
PI4P FLARE was also stabilized at the PM in scs2D scs22D
double mutant cells, particularly in mother cells (the PI4P FLARE
was also weakly observed at intracellular puncta) (Figure 3D).
Thus, Osh3 and Scs2 interact, and the VAP proteins Scs2/
Scs22 control PI4P levels at the PM.
We performed additional tests to address how the VAP
proteins Scs2/Scs22 might control PI4P metabolism. Sac1-
GFP localized to nuclear and cER membrane compartments in
scs2D scs22D double mutant cells (Figure S3A). Steady-state
expression of Sac1-GFP and Osh3-GFP was unaffected in
scs2D scs22Dmutant cells, compared to wild-type cells (Figures
S3B and S3C). Thus, whereas Sac1, Osh3, and the VAP proteins
Scs2/Scs22 act in common to control PI4P metabolism, the VAP
proteins are not required for Sac1 or Osh3 stability. Similar to the
cortical localization of Osh3AAAT-GFP (Figure S2C), Osh3-GFP
localized to cortical structures in scs2D scs22Dmutant cells (Fig-
ure S3D). However, Osh3-GFP cortical patches did not appear to
be associated with the peripheral ER in scs2D scs22D mutant
cells (Figure S3D), consistent with a previous study (Loewen
et al., 2003). These findings suggest that PI4P metabolism at
PM/ER junctions may occur in regulated stages. Osh3 may
initially assemble at the PM, possibly as a PI4P sensor via its
PH domain. Subsequent interactions between Osh3 and the
VAP proteins may lead to stimulation of Sac1 PI phosphatase
activity at PM/ER junctions.
The Osh and VAP Proteins Control Sac1 Phosphatase
Activity
To test if the VAP and Osh proteins regulate Sac1 activity, we set
up an in vitro phosphatase assay using PI4P-containing lipo-somes (PC:PS:PI4P) and microsomes containing integral
Sac1-GFP prepared from cellular membranes (Figures 4A; Fig-
ure S4A). PI4P phosphatase activity was readily detected with
wild-type microsomes (145 pmol/mg total protein/min, at
10 min) (Figure 4A) and was specifically due to Sac1-GFP
because microsomes prepared from sac1D cells lacked activity
(Figure 4A). We also did not detect significant phosphatase
activity using Sac1-GFP microsomal preps against liposomes
lacking PI4P (PC:PS:PtdIns liposomes) (Figure S4B). Thus, this
in vitro assay followed microsome-embedded Sac1 activity
against PI4P presented on liposomes, rather than PI species
that might be present in the microsomes.
To confirm that liposomes did not fuse with Sac1-GFP micro-
somes or that PI4P did not transfer from liposomes to micro-
somes, we incubated Sac1-GFP microsomes with liposomes
containing 3H-labeled PI4P and PI(4,5)P2 (Figure S4C). Following
a 30-min incubation at 37C (the course of the phosphatase
assays) (Figures 4A and Figure S4B), Sac1-GFP microsomes
were immunoisolated using anti-GFP antibodies and protein
A-coupled magnetic Dynabeads (Figure S4D). Unbound lipo-
somes (and microsomes not containing Sac1-GFP) were subse-
quently sedimented by high-speed centrifugation. The amount
of 3H-PI species in isolated Sac1-GFP microsomes, sedimented
liposomes, and the resulting supernatant fraction was deter-
mined by liquid scintillation counting. Only a minor portion,
3.1% ± 0.9% of the total 3H-PI, associated with isolated Sac1-
GFP microsomes (Figure S4E, bound fraction). The bulk of
3H-PI, 93.1% ± 6.2%, was present in the unbound fraction (Fig-
ure S4E). Of 3H-PI in the unbound fraction, 88.5% ± 1.3%
sedimented upon high-speed centrifugation (Figure S4F, P100
fraction), indicating that the majority remained in a membrane
bilayer. A small amount of the unbound fraction, 11.5% ±
1.2%, was found in the supernatant fraction, perhaps due to
micelles that did not sediment (Figure S4F, S100 fraction).
Thus, liposomes did not fuse with Sac1-GFP microsomes, and
3H-PI species were not efficiently transferred from liposomes
to Sac1-GFP microsomes, under conditions that resulted in
efficient dephosphorylation of PI4P in liposomes (Figures 4A
and Figure S4B). We also performed experiments in the
presence of recombinant Osh3 (GST-Osh3588–996 including the
FFAT and ORD; see Figure 5A). However, the distribution of
3H-PI species was not significantly affected by the addition of
GST-Osh3588–996 (Figures S4E and S4F). Similarly, purified
his6-Osh4 (Figure 5A) did not significantly alter the distribution
of 3H-PI species in analogous experiments (unpublished data).
Thus, Osh3 and Osh4 did not enhance membrane fusion or
3H-PI transfer between liposomes and Sac1-GFP microsomes.
Following these control experiments, we addressed whether
the VAP proteins controlled Sac1 PI phosphatase activity. Micro-
somes lacking Scs2 and Scs22 were impaired in the initial rate of
PI4P turnover (more than 2-fold: 66 pmol/mg total protein/min, at
10 min, as compared to wild-type) (Figure 4A). In addition, scs2D
scs22D microsomes were impaired in maximal Sac1 phospha-
tase activity as compared to wild-type microsomes (1232 ±
159 pmol PO4 released versus 2543 ± 274 pmol, respectively)
(Figure 4A). Levels of Sac1-GFP and the ER protein Dpm1
were similar in both wild-type and scs2D scs22D microsomal
preparations (Figure S4A). Thus, whereas Sac1-GFP levelsCell 144, 389–401, February 4, 2011 ª2011 Elsevier Inc. 393
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Figure 4. The VAP Proteins Scs2/Scs22
Control Sac1 PI Phosphatase Activity
In Vitro
(A) PI4P-containing liposomes were incubated
withwild-type (circles), scs2D scs22D (squares), or
sac1D (triangles) microsomes for the indicated
times. Phosphate release was measured by
a malachite green assay. Error bars show the SD
of two experiments measured in duplicate. See
also Figure S4.
(B) Short acyl chain diC8 PI4P was incubated with
wild-type (circles), scs2D scs22D (squares), or
sac1D (triangles) microsomes for the indicated
times. Error bars show the SD of two experiments
measured in duplicate.
(C) Short acyl chain diC8 PI4P was incubated with
untreated (circles), NaCl-washed (triangles), or
NaCl-washed microsomes in the presence of
GST-Osh3588–996 (diamonds) for the indicated
times. Error bars show the SD of two experiments
measured in duplicate. See also Figure S5A.were similar, Sac1 activity was impaired in scs2D scs22Dmicro-
somes. Importantly, to our knowledge, these experiments
provide the first in vitro demonstration of Sac1 activity in trans
and indicate that the yeast VAP proteins promote this activity.
Wild-type and scs2D scs22D microsomes demonstrated
similar activity against a soluble substrate, short acyl chain
diC8 PI4P (in the absence of other lipids) (Figure 4B), indicating
that both microsomal preps contained similar intrinsic Sac1
activity. As in the PI4P liposome assay, microsomes isolated
from sac1D cells did not display activity against diC8 PI4P (Fig-
ure 4B). Notably, both wild-type and scs2D scs22Dmicrosomes
displayed increased activity for the soluble diC8 PI4P substrate
(approximately 1500 pmol PO4 released/mg total protein/min,
after 1 min) (Figure 4B). At later time points both preps continued
to display similar turnover rates, although slower likely due to
reduced substrate concentrations. Thus, the VAP proteins
Scs2/Scs22 may act to link Sac1 to substrates on opposing394 Cell 144, 389–401, February 4, 2011 ª2011 Elsevier Inc.membranes, possibly through the FFAT-
containing Osh proteins, Osh2 and Osh3.
We then tested if the Osh proteins stim-
ulate Sac1 activity in vitro. Because Sac1
levels were reduced in oshD:CEN osh4ts
cell lysates (Figure S1B and Figure S4A),
we did not use microsomes prepared
from these mutant cells. However, we
found that Osh3 was depleted from
membrane fractions by incubation in
high salt (unpublished data). Sac1-GFP
microsomes were then subjected to
a high-salt wash to deplete peripherally
associated membrane proteins, such as
Osh3. Sac1-containing microsomes
were not active against PI4P-containing
liposomes following the high-salt wash.
Thus, wewere not able to test whether re-
combinant Osh3 stimulated Sac1 in transactivity (unpublished data). However, NaCl-washedmicrosomes
displayed a reduced rate of diC8 PI4P turnover (more than
2-fold: 600 ± 115 pmol/mg total protein/min, after 1 min, as
compared to untreated microsomes at 1600 ± 206 pmol/mg total
protein/min, after 1 min) (Figure 4C) andmaximal Sac1 phospha-
tase activity compared to untreated microsomes (1746 ± 213
pmol PO4 released versus 2789 ± 211 pmol, respectively, after
30 min) (Figure 4C). To test if impaired Sac1 activity in
NaCl-washed microsomes was due to the loss of Osh proteins,
purified GST-Osh3588–996 (see Figure 5B) was added back to the
reaction. Strikingly, 0.2 mM GST-Osh3588–996 restored activity in
salt-washed microsomes to levels nearly identical to untreated
Sac1-GFP microsomes (1450 ± 155 pmol/mg total protein/min
after 1 min, and 3000 ± 176 pmol PO4 released after 30 min) (Fig-
ure 4C). Thus, recombinant Osh3 stimulated full-length Sac1 in
microsomes, providing the first evidence that ORPs control
Sac1 PI phosphatase activity in vitro.
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Figure 5. The ORDs Stimulate Sac1 Activity In Vitro
(A) Schematic of the reconstituted Sac1 phosphatase
assay. PI4P-containing liposomes were incubated with
his6-Sac1
1–522, GST-Osh3588–996 or his6-Osh4. Phosphate
release was measured by a malachite green assay. The
Coomassie-stained gel shows the recombinant proteins
used in the in vitro assays. The dot indicates a GST-
Osh3588–996 degradation product.
(B) GST-Osh3588–996 stimulates Sac1 in vitro. Results from
in vitro phosphatase assays including 0.33 mM his6-
Sac11–522 (squares), 0.1 mM his6-Sac1
1–522 (diamonds),
1 mMGST-Osh3588–996 and 0.1 mMSac11–522 (circles), and
background levels in the presence of 1 mM GST-
Osh3588–996 alone (triangles). Error bars show SD of two
experiments measured in duplicate. See also Figure S5B.
(C) Osh4 stimulates Sac1 in vitro. Results from in vitro
phosphatase assays with 0.33 mM his6-Sac1
1–522
(squares), 0.03 mM his6-Sac1
1–522 (diamonds), 0.03 mM
his6-Sac1
1–522 and 12 mM his6-Osh4 (circles), and 12 mM
his6-Osh4 alone (triangles). Error bars show SD of two
experiments measured in duplicate.To test if GST-Osh3588–996 required the VAP proteins to stimu-
late Sac1, Sac1-GFP microsomes prepared from scs2D scs22D
mutant cells were washed with high salt to deplete peripheral
membrane proteins. As expected, NaCl-washed scs2D scs22D
microsomes displayed impaired rates of diC8 PI4P turnover,
compared to untreated scs2D scs22D microsomes (more than
2-fold: 577 ± 151 pmol/mg total protein/min, after 1 min, as
compared to untreated scs2D scs22D microsomes at 1315 ±
186 pmol/mg total protein/min, after 1 min) (Figure S5A). Salt-
washed scs2D scs22D microsomes also displayed reduced
maximal Sac1 phosphatase activity, compared to untreated
scs2D scs22Dmicrosomes (1364± 223pmolPO4 releasedversus
2652± 206pmol, respectively, after 30min) (FigureS5A). Interest-
ingly, 0.2 mMGST-Osh3588–996 restored full activity in salt-washed
scs2D scs22Dmicrosomes (1489 ± 145 pmol/mg total protein/min
after 1 min, and 2994 ± 176 pmol PO4 released after 30 min) (Fig-
ure S5A). Thus, the Osh3 ORD stimulated Sac1 activity against
diC8 PI4P independently of the VAP proteins Scs2 and Scs22.Cell 144, 38Reconstitution of Sac1 Phosphatase
Activation by ORDs
Because the Osh3ORD stimulated Sac1 activity
in microsomes, we tested whether Osh proteins
directly stimulate Sac1. We reconstituted Sac1
phosphatase activity in vitro using purified
components at known concentrations. Sac1
lacking its transmembrane domains was
expressed and purified from bacteria (his6-
Sac11–522) and incubated with PI4P-containing
liposomes (Figure 5A). Purified his6-Sac1
1–522
dephosphorylated PI4P in a dose and time-
dependent manner (400 pmol/min/mg protein
for 0.33 mM his6-Sac1
1–522 after 5 min) (Fig-
ure 5B). At 0.1 mM his6-Sac1
1–522, the turnover
rate was reduced to approximately 250 pmol
PO4 released/min/mg protein after 5min (Figures
5B and Figure S5D). A mutant form of Sac1
bearing substitutions in both cysteine residuesin the CX5R active site (his6-Sac1
C392S, C395S) (Figure S5C) did
not display phosphatase activity against PI4P-containing lipo-
somes (Figure S5D). Importantly, addition of the Osh3 ORD
(GST-Osh3588–996) (Figure 5B) stimulated Sac1 phosphatase
activity 3-fold against PI4P-containing liposomes, as 0.1 mM
his6-Sac1
1–522 in the presence of 1 mM GST-Osh3600–996
displayed a turnover rate similar to 0.33 mM his6-Sac1
1–522 (Fig-
ure 5B). As a control, 1 mM GST alone did not increase Sac1
activity (Figure S5D). GST-Osh3588–996 did not catalyze PI4P
turnover in the absence of his6-Sac1
1–522 (Figure 5B) or in the
presence of inactive his6-Sac1
C392S, C395S (Figure S5D).
Because the ORD is common to all ORPs, we addressed if
Sac1 activation is a conserved function for the Osh proteins.
We then tested if full-length Osh4/Kes1 stimulated Sac1 phos-
phatase activity in vitro. In these assays we lowered the
his6-Sac1
1–522 concentration (to 0.033 mM with activity near
background levels) (Figure 5C). In the presence of 12 mM his6-
Osh4, 0.033 mM his6-Sac1
1–522 activity increased 10-fold over9–401, February 4, 2011 ª2011 Elsevier Inc. 395
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Figure 6. PI Binding Regulates Osh4
Function
(A) The structure of Osh4/Kes1 (Im et al., 2005) is
shown with mutants used in this study. Osh4D1–29
(orange) and Osh4L111D (green) are defective in
sterol binding (Im et al., 2005). Osh43E (R236E,
R242E, R243E; blue) is impaired in PI binding (see
Figures S6A and S6B) (Li et al., 2002). Cholesterol
bound within the structure is shown in yellow.
(B) Coomassie-stained gel showing recombinant,
purified his6-Sac1
1–522 and wild-type and mutant
his6-Osh4 proteins.
(C) In vitro phosphatase assays using 0.1 mM his6-
Sac11–522 and wild-type and mutant Osh43E
proteins (1.2 mM). PI4P liposomes (PC:PS:PI4P,
3:1:1) were tested. Error bars show the SD of two
experiments each measured in duplicate.
(D) In vitro phosphatase assays using 0.1 mM his6-
Sac11–522 and wild-type and mutant Osh43E
proteins (1.2 mM) against short acyl chain diC8
PI4P. Error bars show the SD of two experiments
each measured in duplicate. See also Figure S6C.the course of the experiment, reaching that of 0.33 mM his6-
Sac11–522 (Figure 5C). In addition, at high concentrations
(300 mM) of short acyl chain diC8 PI4P, 1.2 mM his6-Osh4 stimu-
lated 0.1 mM his6-Sac1
1–522 activity greater than 6-fold (Figures
6D and Figure S6C). Thus, the ORDs from Osh3 and Osh4
directly activated Sac1 in vitro.
PI and Sterol Binding Control Osh4 Function
Osh4/Kes1 binds PI lipids in vitro (Li et al., 2002). Consistent with
this, his6-Osh4 sedimentedmore efficiently with PI4P-containing396 Cell 144, 389–401, February 4, 2011 ª2011 Elsevier Inc.liposomes, compared to phosphatidyli-
nositol-containing liposomes (Figure-
S6A). GST-Osh3588–996 also sedimented
more readily with PI4P-containing lipo-
somes than it did with PtdIns-containing
liposomes (Figure S6A). We tested if PI
binding was necessary for Osh4 function
in vitro and in vivo. Substitution of three
basic residues (R236E, K242E, K243E;
termed 3E) (Figure 6A) impairs Osh4 PI
binding (Li et al., 2002). The mutant his6-
Osh43E protein was stably expressed
and purified (Figure 6B). We confirmed
that his6-Osh4
3E was defective in PI
binding using an overlay assay (Fig-
ure S6B). In contrast, wild-type his6-
Osh4 bound PI3P, PI4P, and PI(4,5)P2
(in order of binding affinity) (Figure S6B).
Notably, his6-Osh4
3E did not stimulate
Sac1 activity against PI4P in liposomes
(Figure 6C). In addition, his6-Osh4
3E was
impaired in Sac1 activation against short
acyl chain diC8 PI4P, as compared to
wild-type his6-Osh4 (2-fold versus 6-fold
stimulation, respectively) (Figure 6D).
Consistent with these in vitro results,cellular PI4P levels were 17-fold above wild-type in oshD:CEN
osh4ts cells coexpressing Osh43E at 38C (Table S3), indicating
that PI binding is essential for Osh4 function.
Because the Osh proteins bind sterol lipids in vitro (Im et al.,
2005; Raychaudhuri et al., 2006), we tested if sterol lipids regu-
late Osh-stimulated Sac1 activity. Addition of 250 mMcholesterol
(>800-fold above the Kd of Osh4 for cholesterol) (Im et al., 2005)
did not significantly affect Osh4-stimulated Sac1 activity against
diC8 PI4P (Figure S6C). We also measured in vivo PI levels in
oshD:CEN osh4ts cells coexpressing wild-type OSH4 or the
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Figure 7. The ORD Interacts with Sac1 and
Model for Regulation of PI4P Metabolism
by Osh3, Scs2/Scs22, and Sac1 at PM/ER
Membrane Contact Sites
(A) Sac1-13xmyc specifically interacts with Osh7-
3xHA. Membrane fractions from cells expressing
Osh7-3xHA and Sac1-13xmyc or Sec61-13xmyc
were incubated with cross-linkers, solubilized,
immunoprecipitated with anti-HA beads, and
analyzed by immunoblotting to detect Osh7-Sac1
complexes. See also Figure S7A.
(B) GST-Osh3588–996 induces a conformational
shift in the Sac1 catalytic domain. Emission scans
of 0.06 mM Sac1C341NBD in buffer (red), in the
presence of liposomes (PC:PS:PI4P, 3:1:1,
0.1 mM lipid total; dark gray), liposomes and
0.8 mM GST-Osh3588–996 (blue), liposomes with
0.8 mM GST-PHFAPP1 (green), and buffer alone
(light gray). See also Figure S7.
(C) Model for PI4P turnover at PM/ER membrane
contact sites. High PM PI4P levels recruit and
activate Osh3 at ER/PM contact sites. Interactions
between Osh3 and the VAP proteins Scs2/Sc22
activate ER-localized Sac1.sterol-binding defective mutants, osh4D1-29 or osh4L111D (see
Figure 6A) (Im et al., 2005). In oshD:CEN osh4ts cells coexpress-
ing either Osh4D1–29 or Osh4L111D, PI4P levels were 21- and 19-
fold above wild-type levels (Table S3). Thus, whereas cholesterol
did not alter Sac1 activity in vitro, sterol binding was essential for
Osh4-mediated PI4P metabolism in vivo.
The Osh Proteins Interact with the Sac1 Catalytic
Domain
Because the Osh3 and Osh4 ORDs activated Sac1 in vitro, we
examined if Osh proteins interact with Sac1. We initially used
Osh7 for these experiments because it is expressed at higherCell 144, 389–401levels than Osh3 (2350 Osh7 molecules/
cell versus 600 Osh3 molecules/cell)
(Ghaemmaghami et al., 2003). Osh7
localizes to the cER even though it lacks
a PH domain and FFAT motif (Schulz
et al., 2009) (Figure 1C). A membrane
pellet fraction containing Osh7-3xHA
and Sac1-13xmyc was incubated with
cross-linkers, solubilized, and processed
for co-immunoprecipitation against the
3xHA tag on Osh7. A small fraction of
Sac1-13xmyc specifically isolated with
Osh7-3xHA (Figure 7A), suggesting that
this interaction was transient or possibly
indirect because it required crosslinking.
However, Sac1 is far more abundant in
cells than Osh7 (48,000 Sac1 molecules/
cell) (Ghaemmaghami et al., 2003); thus,
only a small fraction of Sac1 is expected
to co-isolate with Osh7. Importantly,
Osh7-3xHA did not crosslink to another
abundant ER membrane protein, Sec61-13xmyc (Figure 7A). We also observed crosslinking between
3xHA-Osh3 and Sac1-13xmyc (Figure S7A). As a control the
ER transmembrane protein Wbp1 was not isolated with 3xHA-
Osh3 (unpublished data). Together, these results suggested
that multiple Osh proteins interact with Sac1 and that the ORD
is responsible.
Next, we tested if the ORD and Sac1 domains physically
interact in vitro. We were unable to detect a stable complex
between the purified Sac1 domain and Osh3 or Osh4 ORDs
in solution (unpublished data). For this reason we devel-
oped assays to monitor Sac1 and ORD interactions on
a membrane bilayer. The Sac11–522 domain contains three, February 4, 2011 ª2011 Elsevier Inc. 397
cysteine residues: C392 and C395 in the catalytic site and C341
in loop 4 (L4) that resides on the same surface as the catalytic site
(Figure S7B) (Manford et al., 2010). Purified his6-Sac1
C392S, C395S
was covalently labeled with the fluorescent dye NBD at C341
(Sac1C341NBD) (Figure S7B). Movement of NBD from an aqueous
environment to a more hydrophobic environment is accompa-
nied by changes in its spectral properties (e.g., emission wave-
length maximum, termed ‘‘blue shift,’’ and intensity) and, thus,
can be used as an indicator for conformational changes in
a protein as well as membrane association. Sac1C341NBD under-
went a significant increase in NBD fluorescence signal (6.6-fold)
and a shift in themaximum emission wavelength (blue shift) upon
addition of liposomes (Figure 7B), reflecting a membrane-
induced change in the local environment of L4 in the Sac1 cata-
lytic domain. Interestingly, addition of GST-Osh3588–996 reduced
Sac1C341NBD signal intensity in the presence of liposomes (1.7-
fold), consistent with an Osh3-induced shift in L4 of Sac1 to
a less hydrophobic environment (Figure 7B). As a control, GST
fused to the PI4P-binding PH domain from FAPP1 did not alter
the Sac1C341NBD fluorescence signal in the presence of lipo-
somes (Figure 7B). Thus, the Osh3 ORD-induced reduction in
Sac1C341NBD signal intensity was not simply due to competition
for PI4P binding.
To address whether these effects were conferred by another
ORD, we incubated Sac1C341NBD with liposomes either in the
absence or presence of his6-Osh4. Addition of his6-Osh4
reduced Sac1C341NBD signal intensity in the presence of lipo-
somes (1.7-fold) (Figure S7C), similar to GST-Osh3588–996. Inter-
estingly, the Osh43E mutant protein that is defective in PI binding
and Sac1 stimulation did not affect Sac1C341NBD fluorescence
intensity in the presence of liposomes (Figure S7C). Because
a change in NBD fluorescence can be due to effects in
membrane association as well as protein conformational states,
we examined the membrane-binding status of Sac1C341NBD in
the absence and presence of Osh4. Surprisingly, the ability of
his6-Sac1
C341NBD to sediment with liposomes was increased in
the presence of his6-Osh4 (>2-fold) (Figure S7D). Thus, the
reduction in Sac1C341NBD fluorescence intensity by Osh4 was
not due to decreased Sac1 domain membrane binding. Accord-
ingly, the Osh-induced shift in Sac1C341NBD fluorescence inten-
sity may reflect an Osh-induced conformational change in the
Sac1 catalytic domain, consistent with Osh-stimulated Sac1
phosphatase activity in vitro. Moreover, an Osh-induced
increase in membrane association may contribute to Sac1
activation.
DISCUSSION
Sac1-like phosphatases are essential regulators of PI-signaling
networks. We show that the Osh proteins control Sac1 activity.
Members of the ORP family are known to bind sterol and PI lipids
and are implicated in disease (Ngo et al., 2010). We demonstrate
a new role for this family: control of PI4P metabolism through
Sac1 PI phosphatases. Our results also explain how ER-local-
ized Sac1 can regulate PM PI4P levels in trans: via the function
of Osh proteins at PM/ER membrane contact sites as sensors
of PI4P at the PM and activators of the Sac1 phosphatase in
the ER.398 Cell 144, 389–401, February 4, 2011 ª2011 Elsevier Inc.PM PI4P Metabolism Occurs at PM/ER Membrane
Contact Sites
Recent studies have proposed that Sac1 regulates PI4P in cis at
the ER and Golgi, as well as in trans at the PM from the ER (Baird
et al., 2008; Manford et al., 2010). In accord, Sac1 has been
shown to regulate PI4P levels at the ER and Golgi (Faulhammer
et al., 2007; Foti et al., 2001). Our findings and additional
evidence indicate that ER-localized Sac1 controls PM PI4P
pools. First, PI4P accumulates at the PM in cells lacking Sac1
(Figure 1E) (Roy and Levine, 2004). Second, Sac1 does not traffic
to the PM and was not stabilized at the PM in an endocytosis
mutant (Tahirovic et al., 2005). Likewise, cells expressing
a form of Sac1 that is retained in the ER do not display elevated
PI4P levels (Konrad et al., 2002). Last, we demonstrate that full-
length Sac1 in microsomes dephosphorylates PI4P in trans on
distinct liposomes (Figure 4).
We propose that the Osh and VAP proteins function as regu-
lators of Sac1 activity at membrane contact sites. Notably,
Osh3 localization to PM/ER membrane sites was dependent
on PI4P synthesis (Figure 2C), and a mutant form lacking the
PH domain was destabilized from cortical patches (Figure S2C).
We suggest that the PH domain-containing protein Osh3 acts
as a sensor of PI4P levels at the PM and subsequently activates
the Sac1 PI phosphatase at the ER (Figure 7C). Our study also
highlights a role for Scs2 and Scs22 in PI4P metabolism. Cells
lacking Scs2 and Scs22 display elevated PM PI4P levels (Fig-
ure 3). Moreover, Scs2 and Scs22 stimulate Sac1 activity
against PI4P in liposomes (Figure 4A). Scs2 and Scs22 may
activate Osh3 at PM/ER membrane contact sites to control
PM PI4P levels (Figure 7C). The yeast VAP proteins may also
aid in the formation of membrane junctions. Scs2 and Scs22
have been implicated in PM/ER membrane contact site forma-
tion (Loewen et al., 2007). In addition, Scs2 binds anionic phos-
pholipids, including PI4P, in vitro (Kagiwada and Hashimoto,
2007).
Mechanisms for Regulation of Sac1 Activity by the Osh
Proteins
Multiple inputs control Osh protein function. We propose that
PI4P binding to the Osh3 PH domain and Scs2 interactions via
the FFAT motif activate Osh3 at PM/ER membrane contact sites
(Figure 7C). These interactions may then facilitate interactions
between the Osh3 ORD and downstream target proteins such
as Sac1 (Figure 7C). Thus, Osh3 may serve as a ‘‘co-incidence
detector’’ of PI4P, the VAP proteins, and Sac1. We also found
that PI and sterol binding control Osh4/Kes1 function (Figure 6;
Table S3). The Osh proteins control sterol localization in vivo
(Beh and Rine, 2004) and transfer sterol lipids in vitro (Raychaud-
huri et al., 2006). Osh4/Kes1 function required sterol binding
in vivo (Table S3) but was not affected by the addition of choles-
terol in vitro (Figure S6C). The concentrations of Osh4 or PI4P in
our in vitro studies may have bypassed a requirement for sterol
binding. In vivo, the ability of the Osh proteins to extract sterol
lipids may control membrane bilayer rigidity and curvature, and
thus, formation of membrane contact sites (Figure 7C). Notably,
the Osh proteins can tether liposomes in vitro (Schulz et al.,
2009). Alternatively, sterol bindingmay control Osh protein local-
ization in vivo. Consistent with this idea, OSBP localizes to the
ER when bound to cholesterol and to the Golgi when bound to
25-hydroxycholesterol (Peretti et al., 2008).
Osh4/Kes1 also binds PI lipids in vitro (Figure S6;) (Li et al.,
2002). This may be a general feature of ORDs because the
Osh3 ORD showed increased affinity for PI4P liposomes (Fig-
ure S6). A form of Osh4 impaired in PI binding (Figure S6) did
not stimulate Sac1 activity in vitro (Figure 6). Although our results
did not indicate that Osh3 transfers PI lipids (Figure S4), the Osh
proteins may bind PI lipids and present substrates to Sac1 at the
membrane interface. Alternatively, PI binding may be necessary
for productive interactions with Sac1. This idea is supported by
our findings that Osh3 and Osh4 induced changes in
Sac1C341NBD spectral properties in the presence of liposomes,
but PI binding-defective Osh43E was incapable of interacting
with Sac1 (Figures 7 and Figure S7). The Osh-induced effects
on Sac1C341NBD signal intensity may reflect a conformational
change in Sac1 or a shift in the orientation of Sac1 with respect
to the membrane bilayer. In addition PI binding may be neces-
sary for Osh-stimulated Sac1 membrane association
(Figure S7D).
Conserved Functions for the Osh/ORP and VAP Proteins
in PI Metabolism
ORP and VAP proteins may share conserved roles in PI homeo-
stasis. Each of the Osh proteins partially rescues the PI4P
metabolism defects in oshD:CEN osh4ts cells (unpublished
data). Both Osh3 and Osh4 stimulate Sac1 PI phosphatase
activity in vitro (Figure 4, Figure 5, and Figure 6). Osh6 and
Osh7 localize to the peripheral ER (Schulz et al., 2009), and
Osh7 interacts with Sac1 in crosslinking experiments (Figure 7A).
Osh1 localizes to nuclear-vacuole junctions to participate in lipid
metabolism (Levine and Munro, 2001). Osh4 regulates PI4P at
the Golgi (Fairn et al., 2007; Li et al., 2002) where it may regulate
Sac1 activity. Likewise, mammalian ORP and VAP proteins have
been implicated at membrane contact sites. A recent study
found ORP1L and VAP at ER/endosome membrane contact
sites (Rocha et al., 2009). Mammalian VAP proteins control
PI4P metabolism at ER/Golgi membrane contact sites (Peretti
et al., 2008). In addition, bound to 25-hydroxycholesterol,
OSBP localizes to the Golgi and ER/Golgi contact sites (Peretti
et al., 2008).
ORP and VAP proteins may regulate additional PI signaling
networks. Osh7 and Scs2 overexpression rescued the growth
defects of mutant yeast cells with toxic PI3P levels due to loss
of the Sac1-like PI phosphatases Ymr1 and Sjl3, myotubularin
and synaptojanin orthologs (Parrish et al., 2005). Cells lacking
Osh or VAP protein function also display increased cellular
PI3P levels (Table S3). It is unclear which Osh proteins regulate
PI3P metabolism and if Osh and VAP proteins regulate other
Sac1-like PI phosphatases, such as synaptojanins or
myotubularin. Yet, cells lacking Osh function accumulate PI4P
levels similar to sac1 sjl2 sjl3 triple mutant cells (Figure 1) (Foti
et al., 2001), suggesting that they may control Sac1-like activity
encoded by the yeast synaptojanins.
We propose that the Osh proteins act as sensors of PI levels
and regulate the Sac1 PI phosphatase at membrane contact
sites. By retaining Sac1 at the ER, cells can recruit Sac1
to distinct organelle contact sites as needed (e.g., ER/PM,ER/Golgi, ER/endosome, ER/lysosome). This would allow the
cell to maintain a wide range of Sac1 phosphatase activity and
permit use of a common phosphatase (Sac1) to regulate PI lipids
at multiple sites in the cell. Membrane contact sites facilitate
communication between organelles through lipid transfer and
metabolism (Lev, 2010). This elegant system may allow cells to
balance not only PI levels but also other lipids at ER membrane
contact sites because the ER is a major site of lipid synthesis.
Thus, modulation of PI levels by Sac1, the Osh proteins, and
VAP proteins may allow signaling between the ER and compart-
ments along the secretory and endocytic systems, thus linking
ER lipid biosynthesis to multiple membrane compartments in
the cell. Interestingly, both Sac1 and the yeast VAP protein
Scs2 are implicated in phospholipid metabolism (Loewen
et al., 2004; Rivas et al., 1999). In addition, Sac1 has recently
been identified as a component of a protein complex at the ER
involved in sphingolipid metabolism (Breslow et al., 2010).
Thus, future studies on Sac1 may reveal new insights into the
links between membrane homeostasis and PI-signaling
pathways.
EXPERIMENTAL PROCEDURES
Additional details of the Experimental Procedures are provided in the
Extended Experimental Procedures.
Yeast Strains, Plasmids, and Media
Descriptions of strains and plasmids used in this study are in Table S1 and
Table S2. Gene deletions and epitope tags were introduced by homologous
recombination. Standard techniques were used for yeast and bacterial growth.
Expression of recombinant proteins in bacteria is described in the Extended
Experimental Procedures.
Fluorescence Microscopy
Microscopy was performed onmid-log cultures at the indicated temperatures.
Images were obtained with a DeltaVision system equipped with an Olympus
microscope, a 1003 objective, and a Cool Snap HQ digital camera. Images
were deconvolved with softWoRx 3.5.0 software. All results are based on
observations of >100 cells.
PI Analysis
Cellular PI levels were measured as described (Baird et al., 2008). Additional
details are in the Extended Experimental Procedures.
Protein Expression Levels
Cells incubated at the indicated temperatures were harvested, lysed, and the
resulting extracts analyzed by SDS-PAGE and immunoblotting with the
following antibodies: a-Myc (9E10), a-HA (12CA5), a-Pep12, a-Dpm1, and
a-GFP.
Protein-Binding Assays
For Scs2-3xHA and GST-Osh31–613 binding, GST or GST-Osh31–613 immobi-
lized on glutathione sepharose 4B was incubated with Scs2-3xHA lysates
solubilized in PBS containing 0.5% Tween 20, 0.1 mM EDTA, and protease
inhibitors. Beads were washed and analyzed by SDS-PAGE and immunoblot-
ting. For Sac1-13xmyc crosslinking to 3xHA-Osh3 and Osh7-3xHA,
membrane fractions were incubated with 2 mM DSP and DTBP. Complexes
were immunoisolated, reduced to cleave cross-linkers, and analyzed by
SDS-PAGE and immunoblotting.
Sac1 Phosphatase Assays
For microsome assays, membrane fractions were sonicated in 50 mM Tris
(pH 6.8), 150 mM NaCl, 2 mM DTT, 1 mM EDTA to form microsomes.Cell 144, 389–401, February 4, 2011 ª2011 Elsevier Inc. 399
Liposomes (0.6 mMPC:0.2 mMPS:0.2 mMPI4P) were prepared by sonicating
hydrated lipids in reaction buffer (50 mM Tris [pH 6.8], 150 mM NaCl, 2 mM
DTT). Microsomes were incubated with liposomes or diC8 PI4P, and reactions
were stopped with 50 mM N-ethylmaleimide (NEM). Phosphate release was
measured by the addition of Biomol Green and measured at OD620.
For assays with recombinant Sac11–522 and Osh proteins, proteins were
added at indicated concentrations to liposomes or diC8 PI4P in reaction buffer
at the indicated temperatures. Cholesterol-containing liposomes (0.6 mM
PC:0.2 mM PS:0.2 mM PI4P:0.2 mM cholesterol) were prepared as described
above. Reactions were stopped at the indicated times with NEM, and phos-
phate release was assayed as described above.
Lipid-Binding Assays
For overlay assays, lipids solubilized in chloroform:methanol were spotted
onto nitrocellulose as indicated. Membranes were incubated overnight with
purified proteins. Membranes were washed, and bound protein was detected
by immunoblotting. For liposome sedimentation, liposomes were prepared as
described, incubated with purified recombinant proteins, and centrifuged at
100,000 3 g. The supernatant and pellet fractions were resolved by SDS-
PAGE, and proteins were detected by Coomassie staining.
NBD Protein Labeling and Fluorescence Spectroscopy
Purified his6-Sac1
C392S,C395S labeled with IANBD [N,N’-dimethyl-N-(iodoace-
tyl)-N’-(7-nitrobenz-2-oxa-1,3-diazolyl)ethylenediamine] was dialyzed to
remove excess IANBD. See the Extended Experimental Procedures for further
details on fluorescence spectroscopy.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and three tables and can be found with this article online at doi:10.
1016/j.cell.2010.12.034.
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